Skip to main content

Microchip Biotechnologies Licenses GE Microfluidics Patents

NEW YORK (GenomeWeb News) – Microchip Biotechnologies said today that it has licensed certain patents from General Electric’s GE Healthcare division that cover design and methods for creating integrated fluidic microchip devices.
MBI said the license would “significantly enhance” its intellectual property portfolio supporting development of lab-on-a-chip devices. The Dublin, Calif.-based firm said that it would use the licensed technology to develop and market "sample-to-answer" systems for genomic analyses and molecular diagnostics.
"Microfluidic devices will play a critical role in next-generation instrumentation that delivers fully automated, cost-effective bioassay solutions in the life sciences, applied sciences, and molecular diagnostics,” said Stevan Jovanovich, president and CEO of MBI, in a statement.
Financial terms of the alliance were not disclosed.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.